DE60024843D1 - Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten - Google Patents
Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthaltenInfo
- Publication number
- DE60024843D1 DE60024843D1 DE60024843T DE60024843T DE60024843D1 DE 60024843 D1 DE60024843 D1 DE 60024843D1 DE 60024843 T DE60024843 T DE 60024843T DE 60024843 T DE60024843 T DE 60024843T DE 60024843 D1 DE60024843 D1 DE 60024843D1
- Authority
- DE
- Germany
- Prior art keywords
- liposomes
- vaccines
- nucleic acid
- oral use
- use contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99307786 | 1999-10-01 | ||
EP99307786 | 1999-10-01 | ||
PCT/GB2000/003773 WO2001024773A1 (en) | 1999-10-01 | 2000-10-02 | Liposome-entrapped dna oral vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60024843D1 true DE60024843D1 (de) | 2006-01-19 |
DE60024843T2 DE60024843T2 (de) | 2006-08-10 |
Family
ID=8241653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60024843T Expired - Lifetime DE60024843T2 (de) | 1999-10-01 | 2000-10-02 | Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten |
Country Status (11)
Country | Link |
---|---|
US (1) | US7008791B1 (de) |
EP (1) | EP1217989B1 (de) |
JP (1) | JP2003529550A (de) |
KR (1) | KR100744237B1 (de) |
CN (1) | CN1196474C (de) |
AT (1) | ATE312599T1 (de) |
AU (1) | AU7540500A (de) |
CA (1) | CA2386024A1 (de) |
DE (1) | DE60024843T2 (de) |
ES (1) | ES2256043T3 (de) |
WO (1) | WO2001024773A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1519745B1 (de) | 2002-07-05 | 2006-12-20 | Lipoxen Technologies Limited | Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen |
US20060286161A1 (en) * | 2003-05-09 | 2006-12-21 | Steffen Panzner | Injectable liposomal depots for delivering active ingredients |
JP4255396B2 (ja) * | 2004-03-19 | 2009-04-15 | 津田駒工業株式会社 | 水噴射式織機の水受け装置 |
WO2008077413A1 (es) * | 2006-12-22 | 2008-07-03 | Soluciones Biotecnologicas Innovacion Ltda | Vacunas adn en peces |
WO2008114274A1 (en) * | 2007-03-19 | 2008-09-25 | Fresenius Kabi Onclology Ltd. | Proliposomal and liposomal compositions |
CN101940321B (zh) * | 2010-08-06 | 2012-06-20 | 南昌大学 | 动态高压微射流-冻融法制备中链脂肪酸纳米脂质体 |
CN101940320B (zh) * | 2010-08-06 | 2012-08-29 | 南昌大学 | 薄膜分散-动态高压微射流制备中链脂肪酸纳米脂质体 |
EP2708134A1 (de) | 2012-09-17 | 2014-03-19 | Unilever N.V. | Teigzusammensetzungen umfassend eine strukturierte Fettphase |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2305157T3 (es) * | 1996-09-13 | 2008-11-01 | Lipoxen Technologies Limited | Liposomas. |
FR2760193B1 (fr) * | 1997-02-28 | 1999-05-28 | Transgene Sa | Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules |
-
2000
- 2000-10-02 AU AU75405/00A patent/AU7540500A/en not_active Abandoned
- 2000-10-02 JP JP2001527772A patent/JP2003529550A/ja not_active Ceased
- 2000-10-02 DE DE60024843T patent/DE60024843T2/de not_active Expired - Lifetime
- 2000-10-02 WO PCT/GB2000/003773 patent/WO2001024773A1/en active IP Right Grant
- 2000-10-02 EP EP00964471A patent/EP1217989B1/de not_active Expired - Lifetime
- 2000-10-02 CA CA002386024A patent/CA2386024A1/en not_active Abandoned
- 2000-10-02 CN CNB008134766A patent/CN1196474C/zh not_active Expired - Fee Related
- 2000-10-02 ES ES00964471T patent/ES2256043T3/es not_active Expired - Lifetime
- 2000-10-02 AT AT00964471T patent/ATE312599T1/de not_active IP Right Cessation
- 2000-10-02 KR KR1020027003922A patent/KR100744237B1/ko not_active IP Right Cessation
- 2000-10-02 US US10/089,312 patent/US7008791B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2003529550A (ja) | 2003-10-07 |
DE60024843T2 (de) | 2006-08-10 |
EP1217989B1 (de) | 2005-12-14 |
CN1376056A (zh) | 2002-10-23 |
WO2001024773B1 (en) | 2001-08-16 |
CN1196474C (zh) | 2005-04-13 |
KR20030011763A (ko) | 2003-02-11 |
CA2386024A1 (en) | 2001-04-12 |
EP1217989A1 (de) | 2002-07-03 |
ES2256043T3 (es) | 2006-07-16 |
KR100744237B1 (ko) | 2007-07-30 |
AU7540500A (en) | 2001-05-10 |
ATE312599T1 (de) | 2005-12-15 |
WO2001024773A1 (en) | 2001-04-12 |
US7008791B1 (en) | 2006-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11185480B2 (en) | Buffered microencapsulated compositions and methods | |
WO2003030934A3 (en) | Cpg formulations and related methods | |
HUP0302114A2 (hu) | Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása | |
US5665374A (en) | Ultramulsion containing interdental delivery devices | |
ATE198040T1 (de) | Feste fettnanoemulsionen als wirkstoffabgabevehikel | |
ATE355826T1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
ATE186212T1 (de) | Geschmacksmaskierte pharmazeutische mittel | |
DE60119693D1 (de) | Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon | |
HUP9802445A2 (hu) | Liposzómás oligonukleotid készítmények és eljárás human RAF kifejeződésének gátlására | |
ATE74513T1 (de) | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen. | |
HUP0402451A3 (en) | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules | |
AU2001295671A1 (en) | Pharmaceutical composition for immunisation against aids | |
DE60024843D1 (de) | Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten | |
WO2002056900A3 (de) | Verwendung von slpi zur behandlung chronisch-entzündlicher darmerkrankungen | |
ATE234919T1 (de) | Antisense nukleinsäuren zur vorbeugung und behandlung von beschwerden in welchen die exprimierung von c-erbb-2 eine rolle spielt | |
CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
ATE285239T1 (de) | Dna enthaltende impfstoffen | |
FR2819175B1 (fr) | Composition cosmetique et/ou dermatologique acide contenant un polymere amphiphile | |
US5733529A (en) | Ultramulsion based antigingivitis toothpaste compositions | |
EP1248650B1 (de) | Verbesserte dns impfstoffe für rinder-herpes virus 1 | |
WO2001082892A3 (de) | Wirkstoffhaltige liposome | |
WO2003101482A3 (en) | Liposome vaccine formulations for fin-fish | |
DE69018702D1 (de) | Verfahren zur Herstellung eines Antikaries-Impfstoffes aus Streptococcus mutans und Impfzusammensetzung gegen Karies in Form von Nasentropfen. | |
CA2334520A1 (en) | Treatment of immune diseases | |
ATE226065T1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |